I Fundamentals of Gastrointestinal Pharmacology |
|
|
Fundamentals of Gastrointestinal Pharmacology |
|
|
1 | (20) |
|
|
|
|
II Acid-Related Disorders |
|
|
Helicobacter pylori-Induced Gastritis, Ulceration, and Neoplasia Epidemiology, Pathophysiology, and Therapeutics |
|
|
21 | (10) |
|
|
|
|
|
|
|
|
|
Gastroesophageal Reflux Disease |
|
|
31 | (14) |
|
|
|
|
|
Gastric and Duodenal Ulcers |
|
|
45 | (10) |
|
|
|
|
|
Drug-Induced Ulcerogenesis |
|
|
55 | (10) |
|
|
|
|
|
|
|
|
|
Management of Acid Hypersecretion in Patients with Zollinger-Ellison Syndrome |
|
|
65 | (10) |
|
|
|
|
|
Stress Ulcer Prophylaxis A Systematic Review and Evidence-Based Recommendations |
|
|
75 | (4) |
|
|
|
|
III Motility Disorders |
|
|
Pathophysiology of Gastrointestinal Motility Disorders |
|
|
79 | (10) |
|
|
|
|
|
Principles of Gut Pharmacology |
|
|
89 | (8) |
|
|
|
|
|
Pharmacotherapy of the Esophageal Motor Disorders |
|
|
97 | (6) |
|
|
|
|
|
Therapeutic-Pharmacologic Approach to Delayed Gastric Emptying |
|
|
103 | (10) |
|
|
|
|
|
Chronic Intestinal Pseudo-Obstruction |
|
|
113 | (14) |
|
|
|
|
|
|
|
|
IV Functional Gastrointestinal Disorders |
|
|
Pharmacologic Therapy of Irritable Bowel Syndrome |
|
|
127 | (6) |
|
|
|
|
|
Functional Gastrointestinal Disorders Chronic Pain Management |
|
|
133 | (14) |
|
|
|
|
V Pain Management |
|
|
|
147 | (6) |
|
|
|
|
VI Gastrointestinal Water Flux |
|
|
The Pathophysiology of Diarrhea and Constipation The Role of Intestinal Water and Electrolyte Flux |
|
|
153 | (6) |
|
|
|
|
|
Cathartics, Laxatives, and Lavage Solutions |
|
|
159 | (16) |
|
|
|
|
|
|
175 | (18) |
|
|
|
|
VII Infections of the Gut |
|
|
Pathophysiology of Gastrointestinal Infections Host Defenses Versus Microbial Virulence Traits |
|
|
193 | (8) |
|
|
|
|
|
|
|
|
|
Diagnosis and Pharmacotherapy of Infections Esophagitis |
|
|
201 | (14) |
|
|
|
|
|
Pharmacology of Small Bowel Infections Pathogens and Therapeutic Approaches |
|
|
215 | (34) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
249 | (18) |
|
|
|
|
|
|
|
|
VIII Acquired Immunodeficiency Syndrome and the Gut |
|
|
Acquired Immunodeficiency Syndrome and the Gut Pathophysiology |
|
|
267 | (10) |
|
|
|
|
|
|
|
|
|
Esophageal Disease in Acquired Immunodeficiency Syndrome |
|
|
277 | (10) |
|
|
|
|
|
|
|
|
|
The Stomach in Human Immunodeficiency Virus Disease |
|
|
287 | (8) |
|
|
|
|
|
|
295 | (14) |
|
|
|
|
|
|
|
|
|
Colonic Disease in Acquired Immunodeficiency Syndrome |
|
|
309 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
IX Acute and Chronic Noninfections Inflammatory States |
|
|
Agents Commonly Used in the Treatment of Inflammatory Bowel Disease |
|
|
327 | (22) |
|
|
|
|
|
|
|
|
|
|
349 | (18) |
|
|
|
|
|
|
|
|
|
Medical Management of Ulcerative Colitis and Other Colitis Syndromes |
|
|
367 | (8) |
|
|
|
|
|
|
|
|
|
Medical Management of Crohn's Disease |
|
|
375 | (8) |
|
|
|
|
|
|
|
|
X Pharmacologic Therapy of Hepatic Disorders |
|
|
|
383 | (18) |
|
|
|
|
|
Pathophysiology and Pharmacology of Cholestasis |
|
|
401 | (16) |
|
|
|
|
|
|
|
|
|
Treatment of Chronic Cholestatic Liver Disease |
|
|
417 | (32) |
|
|
|
|
|
|
|
|
|
Pharmacology and Medical Management of Hepatic Cirrhosis and Fibrosis |
|
|
449 | (16) |
|
|
|
|
|
|
|
|
|
|
465 | (24) |
|
|
|
|
XI Biliary Pharmacology |
|
|
Primary Sclerosing Cholangitis Pathogenesis and Therapy |
|
|
489 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sphincter of Oddi Current Approaches |
|
|
501 | (12) |
|
|
|
|
|
|
|
|
|
Prevention and Medical Treatment of Gallstones |
|
|
513 | (14) |
|
|
|
|
|
|
|
|
|
Identification and Management of the Hyperlipidemic Patient |
|
|
527 | (14) |
|
|
|
|
|
|
|
|
XII Pancreas |
|
|
Pathophysiology of Acute Pancreatitis |
|
|
541 | (8) |
|
|
|
|
|
Inflammatory Mediators in Acute Pancreatitis |
|
|
549 | (10) |
|
|
|
|
|
Treatment of Acute Pancreatitis From Animal Models to Randomized Human Trials |
|
|
559 | (6) |
|
|
|
|
|
|
|
|
|
Pathophysiology of Chronic Pancreatitis |
|
|
565 | (6) |
|
|
|
|
|
|
|
|
|
Chronic Pancreatitis Pathophysiology and Treatment of Steatorrhea |
|
|
571 | (8) |
|
|
|
|
|
|
|
|
|
Chronic Pancreatitis Pathophysiology and Treatment of Pain |
|
|
579 | (6) |
|
|
|
|
|
|
|
|
XIII Pharmacology of Gastrointestinal Vasculature |
|
|
The Pharmacology of Vasoconstriction |
|
|
585 | (12) |
|
|
|
|
|
The Medical Therapy of Intestinal Ischemia |
|
|
597 | (6) |
|
|
|
|
XIV Special Issues |
|
|
|
603 | (8) |
|
|
|
|
|
Use of Gastrointestinal and Hepatic Drugs During Pregnancy and Lactation |
|
|
611 | (22) |
|
|
|
|
|
|
|
|
|
|
633 | (10) |
|
|
|
|
|
|
|
|
|
|
643 | (12) |
|
|
|
|
|
Considerations in the Geriatric Patient |
|
|
655 | (14) |
|
|
|
|
|
|
|
|
|
Genetics and Gene Therapy for Gastrointestinal Diseases |
|
|
669 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
XV Drug Assessment |
|
|
The Drug Development Process An FDA Perspective |
|
|
677 | (16) |
|
|
|
|
|
Role of the Pharmaceutical Industry in Drug Development |
|
|
693 | (14) |
|
|
|
|
|
|
|
|
|
The Clinical Trials Process |
|
|
707 | (16) |
|
|
|
|
|
|
|
|
|
Development of Gastrointestinal Drugs for Over-the-Counter Indications |
|
|
723 | (20) |
|
|
|
|
|
|
|
|
|
The Economics of Drug Therapy |
|
|
743 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
Index |
|
759 | |